179 related articles for article (PubMed ID: 16007129)
41. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2.
Nitta RT; Smith CL; Kennedy BK
PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003
[TBL] [Abstract][Full Text] [Related]
42. The antiapoptotic protein ICBP90 is a target for protein kinase 2.
Bronner C; Trotzier MA; Filhol O; Cochet C; Rochette-Egly C; Schöller-Guinard M; Klein JP; Mousli M
Ann N Y Acad Sci; 2004 Dec; 1030():355-60. PubMed ID: 15659817
[TBL] [Abstract][Full Text] [Related]
43. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
44. Momilactone B induces apoptosis and G1 arrest of the cell cycle in human monocytic leukemia U937 cells through downregulation of pRB phosphorylation and induction of the cyclin-dependent kinase inhibitor p21Waf1/Cip1.
Park C; Jeong NY; Kim GY; Han MH; Chung IM; Kim WJ; Yoo YH; Choi YH
Oncol Rep; 2014 Apr; 31(4):1653-60. PubMed ID: 24503697
[TBL] [Abstract][Full Text] [Related]
45. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
46. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F.
van Wijnen AJ; van Gurp MF; de Ridder MC; Tufarelli C; Last TJ; Birnbaum M; Vaughan PS; Giordano A; Krek W; Neufeld EJ; Stein JL; Stein GS
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11516-21. PubMed ID: 8876167
[TBL] [Abstract][Full Text] [Related]
47. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
48. ICBP90 expression is downregulated in apoptosis-induced Jurkat cells.
Abbady AQ; Bronner C; Trotzier MA; Hopfner R; Bathami K; Muller CD; Jeanblanc M; Mousli M
Ann N Y Acad Sci; 2003 Dec; 1010():300-3. PubMed ID: 15033738
[TBL] [Abstract][Full Text] [Related]
49. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
Adachi N; Nomoto M; Kohno K; Koyama H
Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
[TBL] [Abstract][Full Text] [Related]
50. p53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression.
Linke SP; Harris MP; Neugebauer SE; Clarkin KC; Shepard HM; Maneval DC; Wahl GM
Oncogene; 1997 Jul; 15(3):337-45. PubMed ID: 9233768
[TBL] [Abstract][Full Text] [Related]
51. Identification and characterization of the putative retinoblastoma control element of the rat insulin-like growth factor binding protein-2 gene.
Kutoh E; Margot JB; Schwander J
Cancer Lett; 1999 Mar; 136(2):187-94. PubMed ID: 10355748
[TBL] [Abstract][Full Text] [Related]
52. The retinoblastoma gene product is reversibly dephosphorylated and bound in the nucleus in S and G2 phases during hypoxic stress.
Amellem O; Stokke T; Sandvik JA; Pettersen EO
Exp Cell Res; 1996 Aug; 227(1):106-15. PubMed ID: 8806457
[TBL] [Abstract][Full Text] [Related]
53. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
Liu S; Yamauchi H
Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
[TBL] [Abstract][Full Text] [Related]
54. A concern regarding the current confusion with the human homolog of mouse Np95, ICBP90/UHRF1.
Unoki M; Bronner C; Mousli M
Radiat Res; 2008 Feb; 169(2):240-4. PubMed ID: 18220474
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
Williams AO; Isaacs RJ; Stowell KM
BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
[TBL] [Abstract][Full Text] [Related]
56. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.
Sellers WR; Novitch BG; Miyake S; Heith A; Otterson GA; Kaye FJ; Lassar AB; Kaelin WG
Genes Dev; 1998 Jan; 12(1):95-106. PubMed ID: 9420334
[TBL] [Abstract][Full Text] [Related]
57. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
[TBL] [Abstract][Full Text] [Related]
58. Alterations of UHRF Family Expression and UHRF1/ICBP90 Inhibits Phosphatase and Tensin Homolog Expression in Endometrial Cancer.
Yoshimoto M; Tokuda A; Eguchi A; Nozawa Y; Mori T; Yaginuma Y
Oncology; 2023; 101(7):457-468. PubMed ID: 37263260
[TBL] [Abstract][Full Text] [Related]
59. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
Fan G; Ma X; Kren BT; Steer CJ
Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
[TBL] [Abstract][Full Text] [Related]
60. Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.
Hedberg Y; Ljungberg B; Roos G; Landberg G
Int J Cancer; 2004 Mar; 109(2):189-93. PubMed ID: 14750168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
